1. Israel Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Holdco Nuvo Group D.G Ltd. Ordinary Shares

Holdco Nuvo Group D.G Ltd. Ordinary Shares

NUVO
Holdco Nuvo Group D.G Ltd. Ordinary SharesUS flagNASDAQ Global Market
0.17
USD
+0.17
- -
5.65MMarket Cap
2021 Y
2022 Y
2023 Y
Revenue per Share
- -
- -
- -
Basic EPS, GAAP
-1.04
-0.62
- -
Free Cash Flow per Basic Share
-0.44
-0.41
- -
Dividend per Share
- -
- -
- -
Book Value per Share
-2.7
-3.32
- -
Tangible Book Value per Share
-0.78
-1.17
- -
Basic Weighted Avg Shares
33
33
- -
Sales/Revenue/Turnover
- -
- -
- -
Operating Margin (%)
- -
- -
-9,450.57
Depreciation Expense
- -
- -
- -
Net Income, GAAP
-35
-21
-34
Effective Tax Rate (%)
- -
- -
- -
Profit Margin (%)
- -
- -
-19,122.16
Working Capital
-27
-39
-29
LT Debt
- -
- -
1
Total Equity
-26
-39
-67
Return on Invested Capital (%)
- -
- -
- -
Return on Capital (%)
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
74.37%
Free Cash Flow
- -
- -
9.25%
Net Income, GAAP
- -
- -
62.75%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
-1.04
2022
- -
- -
- -
- -
-0.62
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Robert Maurice Powell Jr.
Sector
Healthcare
Industry
Medical - Devices
Address
Alon Tower 1 Tel Aviv Israel
IPO Date
Jun 30, 2023
CIK
0001990145
Website
nuvocares.com
Similar Companies
BIOLASE, Inc. (BIOL)
IceCure Medical Ltd (ICCM)
Senzime AB (publ) (SEZI.ST)
Sunridge International, Inc. (SNDZ)
Isoray, Inc. (ISR)
Polarean Imaging plc (PLLWF)
Business
Holdco Nuvo Group D.G Ltd. Holdco Nuvo Group D.G Ltd. is an Israel-based medical technology company that engages in the research, development, and marketing of remote pregnancy monitoring devices and platforms, primarily targeting high-risk pregnancies from the 32nd week until labor; its core offering is the INVU platform, which includes a self-administered wireless sensory band utilizing multi-modality technology to capture real-time maternal and fetal heart rate, uterine activity, and other health metrics, paired with a cloud-based computing environment for data processing, analysis, and delivery of personalized digital reports to expectant mothers and obstetricians via mobile applications for nonstress tests (NST) performed at home or in clinics. The company serves healthcare providers, obstetricians, and patients in Israel, the United States, and internationally, with operations focused on enhancing pregnancy safety and healthcare accessibility through remote monitoring solutions. Founded in 2006 and headquartered in Tel Aviv, Israel, Holdco Nuvo Group D.G Ltd. recently changed its name from Nuvo Group Ltd. in May 2024 following the completion of a business combination with LAMF Global Ventures Corp. I, which resulted in its public listing on Nasdaq under the ticker NUVO before transitioning to OTC; it maintains collaborations with Royal Philips and Charité – Universitätsmedizin Berlin, and in August 2024 filed a voluntary Chapter 11 reorganization petition in the U.S. Bankruptcy Court for the District of Delaware, with subsequent 2024 developments including a motion for asset sale approval for its U.S. subsidiary Nuvo Group USA Inc.